Hyperacetylation escalates myocardial susceptibility to ischemia reperfusion injury by mediating mitochondrial supercomplexes assembly in T2DM.

Bibliographic Details
Title: Hyperacetylation escalates myocardial susceptibility to ischemia reperfusion injury by mediating mitochondrial supercomplexes assembly in T2DM.
Authors: Deng Y; Department of Anesthesiology, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital of Sichuan University, Chengdu, 610041, China; Laboratory of Mitochondrial Metabolism and Perioperative Medicine, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, 610041, China., Yang W; Department of Anesthesiology, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital of Sichuan University, Chengdu, 610041, China; Laboratory of Mitochondrial Metabolism and Perioperative Medicine, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, 610041, China., Yang J; Laboratory of Mitochondrial Metabolism and Perioperative Medicine, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, 610041, China., Ji L; Department of Anesthesiology, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital of Sichuan University, Chengdu, 610041, China; Laboratory of Mitochondrial Metabolism and Perioperative Medicine, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, 610041, China., Xie M; Laboratory of Mitochondrial Metabolism and Perioperative Medicine, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, 610041, China., Tang K; Laboratory of Mitochondrial Metabolism and Perioperative Medicine, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, 610041, China., He Q; Department of Anesthesiology, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital of Sichuan University, Chengdu, 610041, China; Laboratory of Mitochondrial Metabolism and Perioperative Medicine, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, 610041, China., Hu G; Department of Anesthesiology, University of Illinois College of Medicine, Chicago, IL, USA., Shangguan W; Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325027, China. Electronic address: sgwning@163.com., Jiang C; Department of Anesthesiology, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital of Sichuan University, Chengdu, 610041, China; Laboratory of Mitochondrial Metabolism and Perioperative Medicine, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, 610041, China. Electronic address: jiangchunling@scu.edu.cn., Li T; Department of Anesthesiology, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital of Sichuan University, Chengdu, 610041, China; Laboratory of Mitochondrial Metabolism and Perioperative Medicine, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, 610041, China. Electronic address: scutaoli1981@scu.edu.cn.
Source: Redox biology [Redox Biol] 2026 Jun; Vol. 93, pp. 104163. Date of Electronic Publication: 2026 Apr 08.
Publication Type: Journal Article
Language: English
Journal Info: Publisher: Elsevier, B.V Country of Publication: Netherlands NLM ID: 101605639 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2317 (Electronic) Linking ISSN: 22132317 NLM ISO Abbreviation: Redox Biol Subsets: MEDLINE
Imprint Name(s): Original Publication: [Amsterdam]: Elsevier, B.V., [2013]-
MeSH Terms: Sirtuin 3*/genetics , Sirtuin 3*/metabolism , Sirtuin 3*/deficiency , Myocardial Reperfusion Injury*/metabolism , Myocardial Reperfusion Injury*/pathology , Myocardial Reperfusion Injury*/etiology , Myocardial Reperfusion Injury*/genetics , Diabetes Mellitus, Type 2*/metabolism , Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/pathology , Diabetes Mellitus, Type 2*/genetics , Mitochondria, Heart*/metabolism , Mitochondria*/metabolism, Reactive Oxygen Species/metabolism ; Mitochondrial Proteins/metabolism ; Myocardium/metabolism ; Myocardium/pathology ; Diabetes Mellitus, Experimental/metabolism ; Animals ; Acetylation ; Mice ; Mice, Knockout ; Male ; Disease Susceptibility ; Disease Models, Animal
Abstract: Background: Type 2 diabetes mellitus (T2DM) markedly increases susceptibility to myocardial ischemia/reperfusion (I/R) injury, contributing to elevated mortality. Sirtuin 3 (Sirt3), a mitochondrial NAD+-dependent deacetylase, is downregulated in T2DM and is closely associated with mitochondrial protein hyperacetylation, possibly as a mediator of this effect. This study aimed to elucidate the molecular mechanisms underlying increased susceptibility to myocardial I/R injury in T2DM, with a particular focus on Sirt3 deficiency-mediated mitochondrial protein hyperacetylation.
Methods: Wild-type (WT) and Sirt3-knockout (KO) mice were fed a high-fat diet (HFD) for 8 weeks and received intraperitoneal injections of streptozotocin (STZ, 50 mg/kg for three consecutive days) beginning at week 5 to establish a T2DM model. Both in vitro and in vivo models were used to examine the effects of Sirt3 deficiency-induced hyperacetylation on mitochondrial function, reactive oxygen species (ROS) production, and myocardial I/R injury. Mitochondrial supercomplex (SC) assembly and the activities of respiratory chain complexes I, II, III and IV were assessed by blue-native PAGE or a microplate assay kit. Protein-protein interactions were analyzed using proximity ligation assay, and Western blot and functional experiments were performed to explore the underlying molecular mechanisms.
Results: In T2DM, the Sirt3 deficiency-induced mitochondrial protein hyperacetylation significantly increased myocardial susceptibility to I/R injury. Mitochondrial hyperacetylation impaired mitochondrial respiratory function and increased mitochondrial ROS production. Mechanistically, Sirt3 deficiency-induced hyperacetylation of SC-associated mitochondrial proteins disrupted mitochondrial SC assembly, thereby compromising mitochondrial integrity and function.
Conclusions: These findings demonstrate that the increased myocardial susceptibility to I/R injury in T2DM is driven, at least in part, by Sirt3 deficiency-mediated hyperacetylation of mitochondrial SC-associated proteins. Disruption of SC assembly leads to mitochondrial dysfunction and ROS accumulation, providing a mechanistic link between metabolic dysregulation and heightened cardiac I/R injury in T2DM.
(Copyright © 2026 The Authors. Published by Elsevier B.V. All rights reserved.)
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Contributed Indexing: Keywords: Diabetes; Heart; Ischemia-reperfusion injury; Mitochondrial supercomplexes; Protein acetylation; Reactive oxidative species
Substance Nomenclature: EC 3.5.1.- (Sirtuin 3)
0 (Reactive Oxygen Species)
0 (Sirt3 protein, mouse)
0 (Mitochondrial Proteins)
Entry Date(s): Date Created: 20260412 Date Completed: 20260714 Latest Revision: 20260714
Update Code: 20260715
PubMed Central ID: PMC13091559
DOI: 10.1016/j.redox.2026.104163
PMID: 41967292
Database: MEDLINE
Description
ISSN:2213-2317
DOI:10.1016/j.redox.2026.104163